Literature DB >> 9054515

Modulation of the specificity and activity of a cellular promoter in an adenoviral vector.

Q Shi1, Y Wang, R Worton.   

Abstract

Most gene therapy studies with recombinant adenoviruses employ viral promoters and lack tissue specificity. To determine whether a tissue-specific cellular promoter inserted into the adenoviral genome can direct the expression of a reporter gene in a tissue-specific manner, recombinant adenoviruses containing a nuclear lacZ gene driven by a human ventricular/slow muscle myosin light chain 1 promoter with and without a muscle creatine kinase enhancer were constructed. The ability of these viruses to express the reporter genes in infected myogenic and nonmyogenic cell lines was studied. Intramuscular injection of these viruses into mice showed that little or no reporter gene expression occurred in muscle fibers, although a relatively high level of lacZ gene expression was observed in surrounding connective tissue. Insertion of adenovirus sequences from the 5' inverted terminal repeat (ITR) region and/or the protein IX region into plasmids resulted in decreased reporter gene expression from myosin light chain 1 promoter in transfected C2C12 myotubes and 293 cells, as well as in injected muscles. These results suggested that negative elements are present in the adenoviral genome. This negative effect seems neither tissue nor species specific. Adenovirus cis-elements that may affect the specificity and activity of a cellular promoter are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054515     DOI: 10.1089/hum.1997.8.4-403

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  7 in total

1.  Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5/35 vectors.

Authors:  Hongje Wang; Hua Cao; Martin Wohlfahrt; Hans-Peter Kiem; André Lieber
Journal:  Exp Hematol       Date:  2008-04-18       Impact factor: 3.084

2.  Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs.

Authors:  L Gorman; D Suter; V Emerick; D Schümperli; R Kole
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.

Authors:  K Doronin; M Kuppuswamy; K Toth; A E Tollefson; P Krajcsi; V Krougliak; W S Wold
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune Response.

Authors:  Marija Vujadinovic; Kerstin Wunderlich; Benoit Callendret; Marina Koning; Mark Vermeulen; Barbara Sanders; Esmeralda van der Helm; Adile Gecgel; Dirk Spek; Karin de Boer; Masha Stalknecht; Jan Serroyen; Maria Grazia Pau; Hanneke Schuitemaker; Roland Zahn; Jerome Custers; Jort Vellinga
Journal:  Hum Gene Ther       Date:  2017-11-30       Impact factor: 5.695

5.  Variables affecting in vivo performance of high-capacity adenovirus vectors.

Authors:  Gudrun Schiedner; Sabine Hertel; Marion Johnston; Volker Biermann; Volker Dries; Stefan Kochanek
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element.

Authors:  R P Haberman; T J McCown; R J Samulski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  In vivo transcriptional targeting into the retinal vasculature using recombinant baculovirus carrying the human flt-1 promoter.

Authors:  Agustín Luz-Madrigal; Carmen Clapp; Jorge Aranda; Luis Vaca
Journal:  Virol J       Date:  2007-09-18       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.